Cognizant reported strong Q1 2025 results, with revenue rising 7.5% year-over-year to $5.1 billion (8.2% in constant currency), above guidance.

GAAP operating margin was 16.7% and adjusted operating margin was 15.5%, up 210 and 40 basis points, respectively. GAAP EPS rose 22% to $1.34, and adjusted EPS increased 10% to $1.23. Trailing 12-month bookings reached $26.7 billion. The company returned $364 million to shareholders and reaffirmed its 2025 revenue and margin guidance. Growth was led by the Products and Resources segment (+12.8%) and North America (+9.5%), with significant contributions from recent acquisitions.

Cognizant Expands Strategic Partnership with Docusign to Boost Customer Support and Digital Transformation

Cognizant (Nasdaq: CTSH) announced an expanded collaboration with Docusign (Nasdaq: DOCU), aimed at enhancing customer support and accelerating digital transformation initiatives through Intelligent Agreement Management (IAM) solutions.

Under the multi-year agreement, Cognizant will deliver a range of services to Docusign, including technical support, eSignature assistance, billing inquiries, and onboarding consultations. The partnership also includes:

- Real-time customer assistance for rapid issue resolution
- Development of learning resources for effective Docusign deployment
- Enhanced back-office operations for seamless service delivery
- Support for onboarding and integration with external systems

Executives from both companies emphasized the joint effort’s potential to deliver greater efficiency, innovation, and an improved user experience.

Cognizant (Nasdaq: CTSH), a leading provider of information technology, consulting, and business process services, will announce results for the first quarter of 2025 on Wednesday, April 30, 2025 after market close.

OMRON and Cognizant Partner to Advance Sustainable Manufacturing Through IT-OT Integration

OMRON Corporation and Cognizant have announced a strategic partnership aimed at transforming manufacturing operations by integrating Information Technology (IT) and Operational Technology (OT). Under this partnership, Cognizant will serve as the engineering partner for OMRON’s Industrial Automation Business, combining its digital transformation capabilities with OMRON’s automation expertise.

Together, the companies will offer a one-stop solution for sectors such as automotive, semiconductor, electronics, industrial manufacturing, life sciences, and consumer goods. The collaboration leverages OMRON’s field devices like sensors, controllers, and robots, alongside Cognizant’s cloud, AI, IoT, and digital twin technologies.

The integration aims to improve operational flexibility, enhance productivity, reduce greenhouse gas emissions, and promote real-time, data-driven decision-making. Field data collected by OMRON devices will be analyzed through Cognizant’s APEx platform and OnePlant™ tool to optimize manufacturing performance.

Executives from both companies highlighted their commitment to sustainable, autonomous, and connected manufacturing, envisioning an industry shift toward agile, intelligent, and efficient factories of the future.

COGNIZANT AND SERVICENOW LAUNCH AI-POWERED DISPUTE MANAGEMENT SOLUTION FOR MID-MARKET BANKS

On March 27, 2025, Cognizant announced the launch of an AI-powered dispute management solution in partnership with ServiceNow, aimed at mid-market banks in North America. The Business Process as a Service (BPaaS) offering is designed to streamline dispute resolution, reduce operational inefficiencies, and enhance customer satisfaction.

The solution integrates ServiceNow’s dispute management platform with Cognizant’s expertise in end-to-end operations. It includes features such as multi-channel dispute intake, voice and text-based sentiment analysis, automation for operational efficiency, and predictive analytics for workload and recovery. The system uses generative AI to reduce manual intervention and improve outcomes.

Executives from both Cognizant and ServiceNow emphasized the importance of this collaboration in transforming the financial services landscape, while TDECU highlighted the potential for improved customer experiences. The solution represents a broader move toward AI-driven efficiencies in the banking sector.

**Cognizant Expands Stock Buyback Program Ahead of Investor Day**

On March 25, 2025, Cognizant Technology Solutions announced a $2 billion increase to its existing stock repurchase program, ahead of its upcoming Investor Day. The announcement was made via press release, which also outlined the agenda for the event, focused on long-term growth and AI-driven transformation strategies.

The move signals continued confidence in the company’s financial position and shareholder return initiatives. Cognizant’s Class A common stock trades on Nasdaq under the symbol CTSH.

Cognizant Technology Solutions and Gilead Sciences have announced an expansion of their partnership. Cognizant will leverage its Neuro AI generative AI platform to assist Gilead in accelerating value creation, enhancing IT and business processes, and improving operational efficiencies. This initiative aims to provide significant cost savings, which can be reinvested into Gilead's core life sciences business. The collaboration focuses on multiple use cases across customer service, employee interactions, and business value management. Gilead expects to enhance its efficiency by leveraging Cognizant's expertise in AI and advanced technology applications.

Over the last decade, Cognizant has supported Gilead's global IT infrastructure, platforms, applications, and advanced analytics, leading initiatives designed to accelerate its digital transformation. This expanded agreement builds on their collaboration aimed at creating capacity to allow Gilead to continue its focus and mission of discovering and delivering critical medicines for cancer, HIV, and other diseases.

In July 2023, Cognizant and Gilead extended their partnership with a five-year service agreement estimated at $800 million. Under that agreement, Cognizant manages Gilead's global IT infrastructure, platforms, applications, and advanced analytics, leading initiatives designed to accelerate its digital transformation. The collaboration aims to enable Gilead to streamline various parts of its business with the goal of faster time to market for various medicines for life-threatening diseases, including HIV, viral hepatitis, and cancer.

As of January 30, 2025, Cognizant's stock (CTSH) is trading at $82.98, reflecting an increase of 2.21% from the previous close. Gilead Sciences' stock (GILD) is trading at $96.75, up 1.21% from the prior close.